However, HMGB1 may promote tumor invasion, while metastasis reduces anti-tumor immunity by interacting with the receptor for advanced glycation end products (RAGE) and T-cell immunoglobulin domain and mucin domain 3 (TIM3) [199]. This evidence concerns the gene HAVCR2 and neoplasm.